Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Cariogenic bacteria and tooth mineral matrix" represents the pathological interaction between acid-producing oral microorganisms and the inorganic structure of the tooth [NIH NIDCR, 2023]. The primary biological drivers are bacteria such as Streptococcus mutans, which form a complex biofilm (dental plaque) on the tooth surface and ferment dietary carbohydrates into organic acids [StatPearls, 2023]. These acids lower the local pH below the critical level of 5.5, causing the dissolution of the tooth mineral matrix, which is primarily composed of hydroxyapatite [PubMed, PMID: 28753331]. This demineralization process leads to the development of dental caries, a widespread infectious disease characterized by the destruction of enamel and dentin [WHO, 2023]. Therapeutic interventions target this system by either reducing the bacterial load using antiseptics like chlorhexidine or by strengthening the mineral matrix using fluoride [PubChem, CID: 24247]. Fluoride works by facilitating the formation of fluorapatite, which is more resistant to acid than hydroxyapatite, and by inhibiting bacterial metabolic enzymes like enolase [StatPearls, 2023]. Additionally, agents like xylitol and arginine are used to modulate the biofilm's metabolic activity and promote a more alkaline environment [Journal of Dentistry, 2019].
Fluoride ions promote remineralization by forming fluorapatite and inhibit bacterial enolase; Chlorhexidine acts as a broad-spectrum antiseptic by disrupting bacterial cell membranes; Xylitol reduces the growth of Streptococcus mutans by interfering with glucose transport; Arginine metabolism produces ammonia to neutralize plaque acids.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic bacteria and tooth mineral matrix.